Recombinant modified vaccinia virus Ankara expressing glycoprotein E2 of Chikungunya virus protects AG129 mice against lethal challenge.
van den Doel, Petra
Recombinant modified vaccinia virus Ankara expressing glycoprotein E2 of Chikungunya virus protects AG129 mice against lethal challenge. [electronic resource] - PLoS neglected tropical diseases Sep 2014 - e3101 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
1935-2735
10.1371/journal.pntd.0003101 doi
Alphavirus Infections--immunology
Animals
Antibodies, Neutralizing--immunology
Antibodies, Viral--immunology
Chikungunya Fever--prevention & control
Chikungunya virus
Glycoproteins--immunology
Mice
Vaccines, Synthetic--immunology
Vaccinia virus--genetics
Viral Envelope Proteins--immunology
Viral Vaccines--immunology
Recombinant modified vaccinia virus Ankara expressing glycoprotein E2 of Chikungunya virus protects AG129 mice against lethal challenge. [electronic resource] - PLoS neglected tropical diseases Sep 2014 - e3101 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
1935-2735
10.1371/journal.pntd.0003101 doi
Alphavirus Infections--immunology
Animals
Antibodies, Neutralizing--immunology
Antibodies, Viral--immunology
Chikungunya Fever--prevention & control
Chikungunya virus
Glycoproteins--immunology
Mice
Vaccines, Synthetic--immunology
Vaccinia virus--genetics
Viral Envelope Proteins--immunology
Viral Vaccines--immunology